Bortezomib Accord liquid 2.5 mg/1 ml
Bortezomib Accord liquid 2.5 mg/1 ml is a medicine authorised by Swissmedic under authorisation number 68276. The authorisation holder is Accord Healthcare AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 21 October 2021 and the authorisation is valid without a time limit. ATC code L01XG01 places the medicine in the group Antineoplastic agents.
| Authorisation number | 68276 |
|---|---|
| Name | Bortezomib Accord liquid 2.5 mg/1 ml |
| Full name | Bortezomib Accord liquid 2.5 mg/1 ml, Injektionslösung |
| Authorisation holder | Accord Healthcare AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01XG01 |
| First authorisation | 21 October 2021 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Bortezomib Accord liquid 2.5 mg/1 ml, Injektionslösung | A | 21 October 2021 |
| 2 | Bortezomib Accord liquid 3.5 mg/1.4 ml, Injektionslösung | A | 21 October 2021 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | L01XG01 | 07.16.1. | A |
| 2 | 1 | Durchstechflasche(n) | L01XG01 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Bortezomib Accord liquid 2.5 mg/1 ml authorised in Switzerland?
Yes. Bortezomib Accord liquid 2.5 mg/1 ml is authorised by Swissmedic under authorisation number 68276, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Bortezomib Accord liquid 2.5 mg/1 ml have?
Bortezomib Accord liquid 2.5 mg/1 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Bortezomib Accord liquid 2.5 mg/1 ml?
The authorisation holder is Accord Healthcare AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.